[1]
Kamel, A.H. et al. 2025. Impact of Interleukin-6 Serum Levels and rs1800795 Promoter Polymorphism on Disease Activity and Tumor Necrosis Factor Inhibitor Efficacy in Rheumatoid Arthritis . Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ). 9, 1 (Jul. 2025), 118–126. DOI:https://doi.org/10.54133/ajms.v9i1.2146.